N-allyl-N-(3-((2-(3-bromophenylamino)-5-(trifluoromethyl)pyrimidin-4-ylamino)methyl)pyridin-2-yl)methanesulfonamide

ID: ALA3892377

PubChem CID: 134136179

Max Phase: Preclinical

Molecular Formula: C21H20BrF3N6O2S

Molecular Weight: 557.40

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  C=CCN(c1ncccc1CNc1nc(Nc2cccc(Br)c2)ncc1C(F)(F)F)S(C)(=O)=O

Standard InChI:  InChI=1S/C21H20BrF3N6O2S/c1-3-10-31(34(2,32)33)19-14(6-5-9-26-19)12-27-18-17(21(23,24)25)13-28-20(30-18)29-16-8-4-7-15(22)11-16/h3-9,11,13H,1,10,12H2,2H3,(H2,27,28,29,30)

Standard InChI Key:  AZSAXICINIVCFK-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 34 36  0  0  0  0  0  0  0  0999 V2000
    6.4506   -6.1266    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.6335   -6.1412    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    6.0547   -6.8415    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.2426   -1.6839    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2414   -2.5034    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9495   -2.9124    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.6591   -2.5029    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6563   -1.6803    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9477   -1.2750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3597   -1.2691    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0023   -0.8949    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    6.1591   -1.5696    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    5.4928   -0.4255    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    5.3675   -2.9104    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.3834   -3.7274    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0989   -4.1222    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1101   -4.9367    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8247   -5.3314    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.5253   -4.9091    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5068   -4.0879    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7916   -3.6969    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5329   -2.9122    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.4090   -5.3568    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.5919   -5.3672    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1924   -6.0801    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3752   -6.0905    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0656   -6.7287    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5259   -3.7269    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8146   -4.1263    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8073   -4.9402    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5098   -5.3544    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2212   -4.9487    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2250   -4.1362    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0959   -5.3423    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
 10 11  1  0
 10 12  1  0
 10 13  1  0
  8 10  1  0
  7 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
 17 23  1  0
  5 22  1  0
 23 24  1  0
 23  2  1  0
 24 25  1  0
 25 26  2  0
  2 27  1  0
 22 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 33 28  1  0
 30 34  1  0
M  END

Alternative Forms

  1. Parent:

    ALA3892377

    ---

Associated Targets(Human)

PTK2B Tclin Protein tyrosine kinase 2 beta (2827 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTK2 Tclin Focal adhesion kinase 1 (4730 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 557.40Molecular Weight (Monoisotopic): 556.0504AlogP: 4.96#Rotatable Bonds: 9
Polar Surface Area: 100.11Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 13.07CX Basic pKa: 4.18CX LogP: 4.31CX LogD: 4.31
Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.36Np Likeness Score: -1.73

References

1. Farand J, Mai N, Chandrasekhar J, Newby ZE, Van Veldhuizen J, Loyer-Drew J, Venkataramani C, Guerrero J, Kwok A, Li N, Zherebina Y, Wilbert S, Zablocki J, Phillips G, Watkins WJ, Mourey R, Notte GT..  (2016)  Selectivity switch between FAK and Pyk2: Macrocyclization of FAK inhibitors improves Pyk2 potency.,  26  (24): [PMID:27876318] [10.1016/j.bmcl.2016.10.092]

Source